bi 44847
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2006 (NCT02209844)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Sodium/glucose cotransporter 2INHIBITOR
SLC5A2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bi 44847
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02211950 | Phase 1 | Oct 1, 2008 | Boehringer Ingelheim |
| NCT02211924 | Phase 1 | Aug 1, 2007 | Boehringer Ingelheim |
| NCT00558909 | Phase 1 | Jun 1, 2007 | Boehringer Ingelheim |
| NCT02211963 | Phase 1 | Feb 1, 2007 | Boehringer Ingelheim |
| NCT02211937 | Phase 1 | Jan 1, 2007 | Boehringer Ingelheim |
| NCT02209844 | Phase 1 | Aug 1, 2006 | Boehringer Ingelheim |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 6 | 6 | 1 | 2006 |
1 organizations
Page 1 / 1